In Alzheimer’s disease, activated glial cells (particularly astrocytes) produce SFRP1, leading to increased levels of toxic products of APP processing13, which further sustain chronic inflammation16. Here, SFRP1 is linked to early-onset autosomal dominant Alzheimer disease.